Mochi Health has reduced their prices for their GLP-1 weight loss medications. While the membership fees is entirely separate, they have me...

insulin resistance can disrupt reproductive hormones. For women with polycystic ovary syndrome (PCOS), ovulation may become irregular. Gett...

Bayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian ...

Eli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...

India’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...

Earth's natural systems face mounting pressures, with seven of nine planetary boundaries now breached. The Planetary Health Check 2026 high...

Predictions for the 2026 Nobel Prizes in science highlight significant contributions in areas like GLP-1 research and cancer therapies. Car...

While startups such as General Catalyst-backed Voy and Mumbai-based Metago are seeing higher demand from women, Elevate Now, backed by Tita...

Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...

"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...

Consumer demand for protein in everyday staples is driving new product launches and supply deals. Food and beverage makers and cafe chains ...

Doctors express concern over popular injectable peptides for various health benefits. They caution that established peptide medicines diffe...

PGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma...

RPG Life Sciences plans to deploy Rs 500 crore over the next 12 months to expand manufacturing and API capabilities through strategic acqui...

Eli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...

The rising use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro is creating a new consumer market in India, with companies developin...

Diabetes treatment: The researchers said while the study was a rigorous one, based on high quality data from a large representative cohort,...